About Modus QA
Modus QA is a Healthcare company based in London (Canada) founded in 2000, and was acquired by IBA in May 2022. Advanced radiotherapy and medical imaging devices are manufactured. It operates on a Direct-to-Consumer (D2C) and Reseller / Distribution model. Modus QA offers products and services including QUASAR⢠Respiratory Motion Phantom (pRESP 2.0), QUASAR⢠MRIâ´á´° Motion Phantom v1.0, and QUASAR⢠GRIDÂłá´° Advantage System. Its focus areas include Medical Devices and Radiation Therapy Equipment. Its legal entity is Modus Medical Devices Inc.
Company details
Modus QA, now rebranded under IBA Dosimetry as IBA Quasar, is focused on delivering quality assurance solutions for advanced radiotherapy and medical imaging. The companys products, including the QUASAR line, are designed for medical physicists and OEMs to ensure accuracy in motion management, MR-guided radiation therapy, and geometric distortion analysis. Their equipment is built to meet high standards, supporting clinical needs with precision and efficiency. Comprehensive after-sales service is provided to ensure customer confidence. The company operates globally through a network of distributors, enabling accuracy in medical applications worldwide.
Products & Services of Modus QA
Modus QA offers a comprehensive portfolio of products and services, including QUASAR™ Respiratory Motion Phantom (pRESP 2.0), QUASAR™ MRI⁴ᴰ Motion Phantom v1.0, and QUASAR™ GRID³ᴰ Advantage System.
Used for motion management QA in medical imaging.
Evaluates image distortion in 3D MR imaging.
Analyzes image distortion for radiation therapy QA.
Apps and channels of Modus QA
its YouTube channel Modus QA has 508 subscribers and 30 videos.
Videos from Modus QA
The most watched videos on Modus QA's YouTube channel, Modus QA (508 subscribers). Click a video to play it here.
More on Modus QA.
Investors in Modus QA
Modus QA has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include IBA.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Innovative solutions for cancer treatment and industrial applications are provided by IBA. | 1986 | iba-worldwide.com |
Investor details for Modus QA
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Modus QA
2 dated milestones of Modus QA across 22 years, from founding to its latest funding, stage changes and deals.
- Founded Modus QA is founded.
- Exit Acquired by IBA.
Web traffic of Modus QA
The website of Modus QA (modusqa.com) receives about 2.8K visits a month.
- Monthly visits2.8K
▲ 18.1% vs previous month
Websites whose visitors overlap most with Modus QA. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| protectear.com | 100% | 34.1K | #1,090,640 | View details | |
innovativebiomedical.com | innovativebiomedical.com | 99% | #8,081,987 | â | |
bestmedicalcanada.com | bestmedicalcanada.com | 97% | #14,116,303 | â | |
cdrpositioning.com | cdrpositioning.com | 97% | #9,249,998 | â | |
stuarthunt.com | stuarthunt.com | 95% | #3,758,833 | â | |
| â˘â˘â˘â˘â˘â˘â˘â˘â˘â˘ | â˘â˘â˘â˘â˘â˘.com | â˘â˘% | â˘.â˘M | #â˘â˘â˘â˘â˘ | â |
| â˘â˘â˘â˘â˘â˘â˘â˘â˘â˘ | â˘â˘â˘â˘â˘â˘.com | â˘â˘% | â˘.â˘M | #â˘â˘â˘â˘â˘ | â |
| â˘â˘â˘â˘â˘â˘â˘â˘â˘â˘ | â˘â˘â˘â˘â˘â˘.com | â˘â˘% | â˘.â˘M | #â˘â˘â˘â˘â˘ | â |
All 16 similar websites and full traffic analytics for Modus QA
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 16 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track â from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Modus QA
Modus QA was founded in 2000.
Modus QA is headquartered in London, Canada. It is registered at London, Ontario, Canada.
Modus QA, now rebranded under IBA Dosimetry as IBA Quasar, is focused on delivering quality assurance solutions for advanced radiotherapy and medical imaging. The companys products, including the QUASAR line, are designed for medical physicists and OEMs to ensure accuracy in motion management, MR-guided radiation therapy, and geometric distortion analysis. Their equipment is built to meet high standards, supporting clinical needs with precision and efficiency. Comprehensive after-sales service is provided to ensure customer confidence. The company operates globally through a network of distributors, enabling accuracy in medical applications worldwide.
Modus QA offers QUASAR⢠Respiratory Motion Phantom (pRESP 2.0), QUASAR⢠MRIâ´á´° Motion Phantom v1.0, and QUASAR⢠GRIDÂłá´° Advantage System.
Modus QA has 1 investor. Key investors include IBA.
Modus QA operates through Modus Medical Devices Inc..
Yes. Modus QA was acquired by IBA in May 2022.